|
Liam Ratcliffe is a Venture Partner and concentrates
on our biopharmaceuticals efforts. Liam joined New Leaf in
September 2008. Liam most recently served as Senior Vice
President and Development Head for Pfizer Neuroscience, as
well as Worldwide Head of Clinical Research and Development.
Additional positions at Pfizer included Vice President of
Exploratory Development for the Mid West region, and Head of
Experimental Medicine at Pfizer’s Sandwich, UK Laboratories.
As Head of Neurosciences, Liam was responsible for the
development of several successful late-stage projects and
marketed products, including PD 332, 334, Lyrica, Chantix
and Geodon. In previous roles, he gained extensive
experience in early drug development and translational
research across multiple therapeutic areas, including
inflammation, pain, cardiovascular disease, infectious
diseases and genitor-urinary medicine.
Liam began his career in the pharmaceutical industry in a
medical marketing role at Roche in South Africa. He received
his M.D. degree and Ph.D. degree in immunology from the
University of Cape Town and his M.B.A. degree from the
University of Michigan. Liam completed his internal medicine
training and fellowship in Immunology at Groote Schuur
Hospital and additional teaching hospitals in Cape Town,
South Africa.
Board Seats:
Afferent Pharmaceuticals,
Neuronetics
Contact Information:
liam@nlvpartners.com
(646) 871-6400
|
 |
